scispace - formally typeset
B

Boyka Stoykova

Researcher at Brunel University London

Publications -  15
Citations -  971

Boyka Stoykova is an academic researcher from Brunel University London. The author has contributed to research in topics: Cost effectiveness & Health care. The author has an hindex of 9, co-authored 15 publications receiving 928 citations. Previous affiliations of Boyka Stoykova include University of York.

Papers
More filters
Journal ArticleDOI

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.

TL;DR: Routine HPV testing did not add significantly to the effectiveness of LBC in this study, and it would not be cost-effective to screen with cytology and HPV combined but HPV testing, as either triage or initial test triaged by cytology, would be cheaper than cytology without HPV testing.
Journal ArticleDOI

Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health Authorities

TL;DR: There was a general consensus among decision makers in favor of developing a quality-scoring system for studies, thereby going beyond the critical summaries given in NHS EED, but methodological improvements are necessary to increase the reliability of economic studies.
Journal ArticleDOI

Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study.

TL;DR: In this paper, the authors evaluated the clinical and economic impact of stress echocardiography (SEcho) when compared with exercise ECG (ExECG) in the assessment of patients with suspected acute coronary syndrome (ACS), non-diagnostic electrocardiogram (ECG), and negative troponin.
Journal ArticleDOI

A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: cost analysis.

TL;DR: There was no difference in cost to diagnosis between initial ETT and MPI, and in low-likelihood patients ETT was less costly, whereas there was no cost difference in intermediate- or high- likelihood patients.